September 01, 2014 11:31 PM ET

Capital Markets

Company Overview of TVM Capital GmbH

Company Overview

TVM Capital GMBH is private equity and venture capital firm specializing in seed, startup, early stage, mid, late stage, growth capital and buyout investments. It seeks to invest in companies that have spun-out from institutes, universities, and the Research and Development departments of pharmaceutical companies. The firm may also invest in family owned businesses and in all stages of the product life cycle from its earliest stages like material and design innovation through late stage opportunities brought about by business model and execution innovation. It invests in the life sciences with a focus on integrated drug discovery, drug delivery and drug development companies, international p...

Ottostrasse 4

Munich,  80333

Germany

Founded in 1983

Phone:

49 89 99 89 92 0

Fax:

49 89 99 89 92 55

Key Executives for TVM Capital GmbH

Chief Executive Officer
Age: 55
General Partner Corporate Finance and Chief Financial Officer
Managing Partner
Age: 48
Managing Partner
General Partner
Compensation as of Fiscal Year 2014.

TVM Capital GmbH Key Developments

TVM Capital GmbH Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-14-2014 10:10 AM

TVM Capital GmbH Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-14-2014 10:10 AM. Venue: London, United Kingdom. Speakers: Axel Polack, General Partner.

TVM Capital GmbH Presents at The 2014 Life Sciences and Healthcare Venture Summit, Apr-02-2014 03:00 PM

TVM Capital GmbH Presents at The 2014 Life Sciences and Healthcare Venture Summit, Apr-02-2014 03:00 PM. Venue: 55 Broad Street – 4th Floor, New York, New York, United States. Speakers: Cynthia Lavoie, General Partner.

Bukwang Pharm. Co. Ltd. and TVM Capital Life Science Signs Global Partnership Agreement

Bukwang Pharm. Co. Ltd. and TVM Capital Life Science announced that both companies signed a global partnership agreement. The company’s products portfolio includes a range of agents to treat metabolic disease, gastrointestinal disorders, cancer as well as CNS disorders. As part of the agreement, TVM Capital Life Science will support Bukwang with relevant clinical stage business development opportunities from the wider TVM Capital Life Science network in Canada, the USA and Europe in Bukwang’s core therapeutic areas as described above.

Recent Private Companies Transactions

Type
Date
Target
Private Placement
August 11, 2014
FAAH Pharma Inc.
Private Placement
June 23, 2014
Definiens AG
Private Placement
May 22, 2014
PRCL Research Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TVM Capital GmbH, please visit www.tvm-capital.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.